OBJECTIVE: The aim of this study is to evaluate the eficacy about reducing intraocular pressure (IOP) in patients with primary angle glaucoma treated with non penetrating deep sclerectomy with SkGel implant. METHODS: This is an observacional, retrospective study from revision of charts from Tadeu Cvintal Eye Institute. We evaluated 45 eyes from 37 patients that undergone to non penetrating deep sclerectomy with SkGel Implant in the past 10 years. IOP was checked 12 months in a period of 10 years, from 1997 thru 2007. All patients had uncontrolled IOP with maximum antiglaucoma medications or controlled IOP with progressive glaucoma damage. RESULTS: there was 37 patients, 23 (62,16%) were female and 14 (37,83%) were male, with 45 eyes in total. The mean age was 57,4 +/- 14,5 years. The mean IOP before surgery was 20,50 +/- 6,40 mmhg, after 12 months from surgery the mean IOP was -6,50 mmhg +/- 7,20 mmhg. The absolute IOP rate success (IOP<21 mmhg without antiglaucoma medication) and relative (IOP<21 mmhg with antiglaucoma medication) were 71,10% and 26,70%. CONCLUSION: Non penetrating deep sclerectomy with SkGel Implant can be a good way to treat patients with primary angle glaucoma.
Intraocular pressure; Glaucoma; Glaucoma drainage implants; Sclerostomy; Glaucoma, open-angle
